N4 Pharma (LON:N4P) Trading Up 42.9% – Still a Buy?

by · The Markets Daily

N4 Pharma Plc (LON:N4P – Get Free Report)’s share price shot up 42.9% during trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.75 ($0.01). 7,667,071 shares changed hands during trading, an increase of 309% from the average session volume of 1,873,907 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Trading Up 24.8 %

The stock has a market capitalization of £2.59 million, a P/E ratio of -55.00 and a beta of -0.37. The stock’s fifty day moving average price is GBX 0.62 and its two-hundred day moving average price is GBX 0.57. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.

N4 Pharma Company Profile

(Get Free Report)

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.

Featured Stories